SSTR2 and neoplasm: Further research showed that miR-185 targeted SSTR2 mRNA to downregulate SSTR2 protein expression, promote proliferation, and inhibit apoptosis of tumor cells, which would be classified as an oncogene in GH-secreting PA cells [81].